Expression of the hMLH1 and hMSH2 proteins in normal tissues: relationship to cancer predisposition in hereditary non-polyposis colon cancer

. 2005 Feb ; 446 (2) : 112-9. [epub] 20041210

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid15735976

The majority of tumours in patients with hereditary non-polyposis colon cancer (HNPCC) occur in large intestine and endometrium; also, other tissues are at increased risk. We studied expression of hMLH1 and hMSH2 proteins in 148 normal samples of various tissues from non-HNPCC patients and in 14 normal colon tissues from HNPCC patients. Immunohistochemical technique was used. Intensity of nuclear staining, percentage of stained cells and H-scores were calculated. Tissues were divided into groups. Groups A, B and C included tissues with increased risk of cancer in HNPCC A) stomach, small and large bowel; (B) endometrium; (C) ovary, ureter, urinary bladder, kidney and liver. Group D tissues were without increased risk. Expression of the proteins was significantly higher in groups A, B and C compared with group D (P<0.0001, P=0.0004 for hMSH2 in C versus D). The expression was highest in testis. In colons of HNPCC patients, expression of the mutated gene product was significantly lower than in non-HNPCC patients. In conclusion, hMLH1/hMSH2 protein expression is constitutively higher in certain cell types of certain tissues, including the majority of tissues that are at increased risk of cancer in HNPCC. However, association of strong hMLH1/hMSH2 expression with cancer risk is not strictly valid.

Zobrazit více v PubMed

J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65 PubMed

Cancer Res. 1996 Jan 15;56(2):235-40 PubMed

Am J Med. 1994 Jun;96(6):516-20 PubMed

Fertil Steril. 2002 Jul;78(1):195-6 PubMed

Cell. 2002 Jan 25;108(2):171-82 PubMed

Cancer. 2002 Feb 15;94(4):997-1005 PubMed

Cancer Res. 1998 Feb 15;58(4):767-78 PubMed

Dis Colon Rectum. 1988 May;31(5):372-7 PubMed

Virchows Arch. 2001 Jan;438(1):39-48 PubMed

Gastroenterology. 1993 May;104(5):1535-49 PubMed

Chem Biol. 1996 Jul;3(7):579-89 PubMed

Br J Cancer. 1997;76(7):890-3 PubMed

Cell Death Differ. 2001 Nov;8(11):1076-92 PubMed

Cancer Res. 2001 Jul 1;61(13):5193-201 PubMed

Science. 1993 May 7;260(5109):812-6 PubMed

Nat Genet. 1995 Sep;11(1):64-70 PubMed

J Clin Oncol. 2002 Mar 1;20(5):1203-8 PubMed

Cancer Res. 1999 Jan 15;59(2):290-3 PubMed

Cancer Res. 2002 Dec 15;62(24):7316-27 PubMed

J Natl Cancer Inst. 1988 Sep 21;80(14):1170-2 PubMed

Clin Cancer Res. 1998 Jan;4(1):1-6 PubMed

Cancer Res. 2002 Jan 15;62(2):359-62 PubMed

Cancer Res. 1999 Jul 1;59(13):3021-7 PubMed

Cell Death Differ. 2001 Nov;8(11):1049-51 PubMed

Science. 1997 Nov 7;278(5340):1043-50 PubMed

Int J Cancer. 1995 Dec 20;64(6):430-3 PubMed

Cancer Res. 1997 Jan 15;57(2):206-8 PubMed

Cancer. 1993 Feb 1;71(3):677-85 PubMed

Mol Pathol. 1998 Jun;51(3):131-7 PubMed

Int J Cancer. 1999 Apr 12;81(2):214-8 PubMed

J Natl Cancer Inst. 1991 Jun 19;83(12):880-1 PubMed

Histopathology. 2001 Sep;39(3):250-8 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace